Literature DB >> 24365803

Organizational factors as predictors of tobacco cessation pharmacotherapy adoption in addiction treatment programs.

Jessica L Muilenburg1, Tanja C Laschober, Lillian T Eby.   

Abstract

OBJECTIVES: This study investigated 3 organizational factors (ie, counseling staff clinical skills, absence of treatment program obstacles, and policy-related incentives) as predictors of tobacco cessation pharmacotherapy (TCP) adoption (comprised of the 9 available TCPs) in addiction treatment programs using the innovation implementation effectiveness framework.
METHODS: Data were obtained in 2010 from a random sample of 1006 addiction treatment program administrators located across the United States using structured telephone interviews.
RESULTS: According to program administrator reports, TCP is adopted in approximately 30% of treatment programs. Negative binomial regression results show that fewer treatment program obstacles and more policy-related incentives are related to greater adoption of TCP. Counter to prediction, clinical skills are unrelated to TCP adoption.
CONCLUSIONS: Our findings suggest that organizational factors, on the basis of established theoretical frameworks, merit further examination as facilitators of the adoption of diverse TCP in addiction treatment programs.

Entities:  

Mesh:

Year:  2014        PMID: 24365803      PMCID: PMC4000618          DOI: 10.1097/ADM.0000000000000008

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  29 in total

1.  Alcohol abusers who want to quit smoking: implications for clinical treatment.

Authors:  T P Ellingstad; L C Sobell; M B Sobell; P A Cleland; S Agrawal
Journal:  Drug Alcohol Depend       Date:  1999-05-03       Impact factor: 4.492

2.  Putting drug abuse research to use in real-life settings.

Authors:  Glen R Hanson; Alan I Leshner; Betty Tai
Journal:  J Subst Abuse Treat       Date:  2002-09

3.  Response to nicotine dependence treatment in smokers with current and past alcohol problems.

Authors:  J T Hays; D R Schroeder; K P Offord; I T Croghan; C A Patten; R D Hurt; D E Jorenby; M C Fiore
Journal:  Ann Behav Med       Date:  1999

4.  The use of causal indicators in covariance structure models: some practical issues.

Authors:  R C MacCallum; M W Browne
Journal:  Psychol Bull       Date:  1993-11       Impact factor: 17.737

5.  Smoking cessation services in U.S. methadone maintenance facilities.

Authors:  Kimber P Richter; Won S Choi; Robert M McCool; Kari J Harris; Jasjit S Ahluwalia
Journal:  Psychiatr Serv       Date:  2004-11       Impact factor: 3.084

6.  Testing the effectiveness of cognitive-behavioral treatment for substance abuse in a community setting: within treatment and posttreatment findings.

Authors:  J Morgenstern; K A Blanchard; T J Morgan; E Labouvie; J Hayaki
Journal:  J Consult Clin Psychol       Date:  2001-12

7.  Are smokers with alcohol disorders less likely to quit?

Authors:  N Breslau; E Peterson; L Schultz; P Andreski; H Chilcoat
Journal:  Am J Public Health       Date:  1996-07       Impact factor: 9.308

8.  A population-based study of cigarette smoking among illicit drug users in the United States.

Authors:  Kimber Paschall Richter; Harsohena K Ahluwalia; Michael C Mosier; Niaman Nazir; Jasjit S Ahluwalia
Journal:  Addiction       Date:  2002-07       Impact factor: 6.526

9.  Naltrexone treatment for alcoholics: effect on cigarette smoking rates.

Authors:  Damaris J Rohsenow; Peter M Monti; Suzanne M Colby; Suzy B Gulliver; Robert M Swift; David B Abrams
Journal:  Nicotine Tob Res       Date:  2003-04       Impact factor: 4.244

10.  Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort.

Authors:  R D Hurt; K P Offord; I T Croghan; L Gomez-Dahl; T E Kottke; R M Morse; L J Melton
Journal:  JAMA       Date:  1996-04-10       Impact factor: 56.272

View more
  18 in total

1.  Substance Use Disorder Counselors' Reports of Tobacco Cessation Services Availability, Implementation, and Tobacco-related Knowledge.

Authors:  Jessica L Muilenburg; Tanja C Laschober; Lillian T Eby
Journal:  J Adolesc Health       Date:  2015-09       Impact factor: 5.012

2.  Misuse of atypical antipsychotics in conjunction with alcohol and other drugs of abuse.

Authors:  Tara Malekshahi; Nina Tioleco; Nahima Ahmed; Aimee N C Campbell; Deborah Haller
Journal:  J Subst Abuse Treat       Date:  2014-07-23

Review 3.  Achieving Smoking Cessation Among Persons with Opioid Use Disorder.

Authors:  Cynthia Vlad; Julia H Arnsten; Shadi Nahvi
Journal:  CNS Drugs       Date:  2020-04       Impact factor: 5.749

4.  Quitting smoking during substance use disorders treatment: Patient and treatment-related variables.

Authors:  Barbara K Campbell; Thao Le; Barbara Tajima; Joseph Guydish
Journal:  J Subst Abuse Treat       Date:  2016-11-10

5.  Relationship between Low-Income Patient Census and Substance Use Disorder Treatment Programs' Availability of Tobacco Cessation Services.

Authors:  Jessica L Muilenburg; Tanja C Laschober; Lillian T Eby
Journal:  J Drug Issues       Date:  2015-01

6.  Cigarette use is increasing among people with illicit substance use disorders in the United States, 2002-14: emerging disparities in vulnerable populations.

Authors:  Andrea H Weinberger; Misato Gbedemah; Melanie M Wall; Deborah S Hasin; Michael J Zvolensky; Renee D Goodwin
Journal:  Addiction       Date:  2017-12-19       Impact factor: 6.526

7.  Sustained, new, never, and discontinued tobacco cessation services adopters.

Authors:  Lillian T Eby; Tanja C Laschober; Jessica L Muilenburg
Journal:  J Subst Abuse Treat       Date:  2014-08-07

8.  Behavioral Healthcare Staff Attitudes and Practices Regarding Consumer Tobacco Cessation Services.

Authors:  J Randy Koch; Alison Breland
Journal:  J Behav Health Serv Res       Date:  2017-07       Impact factor: 1.505

9.  Medicaid, Private Insurance, and the Availability of Smoking Cessation Interventions in Substance Use Disorder Treatment.

Authors:  Hannah K Knudsen; Paul M Roman
Journal:  Psychiatr Serv       Date:  2015-08-03       Impact factor: 3.084

10.  Missed opportunities to test the neuropsychiatric safety--and efficacy--of varenicline among smokers with substance use disorders.

Authors:  Shadi Nahvi; Julia H Arnsten
Journal:  Drug Alcohol Depend       Date:  2018-02-22       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.